GEHC vs HCAT
GEHC: GE HealthCare is a leading global medical technology provider delivering advanced diagnostic imaging, clinical systems, and intelligent digital solutions to healthcare providers worldwide. HCAT: Health Catalyst provides cloud-based data analytics and improvement services to healthcare systems, but faces significant headwinds from customer financial strain, platform migration challenges, and macroeconomic pressures on healthcare budgets.
Side-by-side fundamentals
| Metric | GEHC | HCAT | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $61.12 | $2.15 | |
| Market cap as of 2026-07-30 | $27.8B | $161M | |
| P/E as of 2026-07-30 | 17.12 | n/a | |
| PEG as of 2026-07-30 | 2.18 | -0.00 | HCAT lower |
| Net margin as of 2026-07-30 | +9.1% | -87.7% | GEHC higher |
| Gross margin as of 2026-07-30 | +39.1% | +50.4% | HCAT higher |
| Operating margin as of 2026-07-30 | +12.6% | -81.7% | GEHC higher |
| ROE as of 2026-07-30 | +18.8% | -99.8% | GEHC higher |
| ROA as of 2026-07-30 | +5.3% | -50.1% | GEHC higher |
| Debt / equity as of 2026-07-30 | 0.95 | 1.11 | GEHC lower |
| Revenue growth (YoY) as of 2026-07-30 | +6.0% | -2.8% | GEHC higher |
| Revenue CAGR (3y) SEC XBRL | +4.0% | +4.0% | Tie |
| Dividend yield as of 2026-07-30 | +0.2% | n/a | |
| Dividend streak (yrs) SEC XBRL | 3 | n/a | |
| Beta as of 2026-07-30 | 0.83 | 1.54 | |
| 1-year return as of 2026-07-27 close | -21.2% | -44.6% | GEHC higher |
Fundamentals: market data, as of 2026-07-30. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.